COGNITION THERAPEUTICS INC (CGTX)
US19243B1026 - Common Stock
COGNITION THERAPEUTICS INC
NASDAQ:CGTX (12/18/2024, 5:42:01 PM)
After market: 0.5854 +0.01 (+0.93%)0.58
+0.13 (+27.5%)
Company Profile
Cognition Therapeutics, Inc. is a clinical stage neuroscience company, which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 25 full-time employees. The company went IPO on 2021-10-08. The firm is investigating its lead candidate CT1812 in clinical programs in Alzheimer's disease, dementia with Lewy bodies and dry age-related macular degeneration (dry AMD). Its lead product candidate, CT1812, is an investigational orally delivered, small molecule modulator that penetrates the blood-brain and blood-retina barriers and binds selectively to the sigma-2 receptor (S2R) complex; and through its modulation of S2R restores normal function of synapses, as well as critical cellular processes such as autophagy, cholesterol biosynthesis, vesicle trafficking, progesterone signaling, lipid membrane-bound protein trafficking and receptor stabilization at the cell surface. The company is developing other product candidates in the area of synucleinopathies.
Company Info
COGNITION THERAPEUTICS INC
Suite 261, 2403 Sidney Street
Pittsburgh PENNSYLVANIA
P: 14127701621
Employees: 25
Website: https://cogrx.com/
CGTX News
3 hours ago - ChartmillWhich stocks are experiencing notable movement on Wednesday?Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
4 hours ago - ChartmillThese stocks are the most active in today's sessionGet a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
5 hours ago - ChartmillKeep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.Let's take a look at the stocks that are in motion in today's session.
7 hours ago - ChartmillTraders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
9 hours ago - ChartmillThese stocks are moving in today's pre-market sessionAs the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
11 hours ago - Cognition Therapeutics, Inc.Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy BodiesCGTX Twits
Here you can normally see the latest stock twits on CGTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
